Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015995 |
---|---|
Receipt number | R000018598 |
Scientific Title | A phase 2 clinical trial of a replication-competent, recombinant herpes simplex virus type 1 in patients with glioblastoma |
Date of disclosure of the study information | 2014/12/18 |
Last modified on | 2020/06/26 15:57:00 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/12/18 21:29:13 | ||
2 | Update | 2018/08/06 17:48:45 | Recruitment status |
|
3 | Update | 2018/08/06 17:51:11 | Name of primary person or sponsor Organization Category of Funding Organization |
|
4 | Update | 2019/03/14 20:20:27 | UMIN ID1 UMIN ID2 |
|
5 | Update | 2020/06/26 14:48:41 | Recruitment status Date of IRB Last follow-up date |
|
6 | Update | 2020/06/26 15:57:00 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Zip code Name of person sending information Name of person sending information TEL Organization Organization Address Address Tel |